Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine: Feature
Genomic cancer medicine promises revolutionary change in oncology. The impacts of 'personalized medicine', based upon a molecular classification of cancer and linked to targeted therapies, will extend from individual patient outcomes to the health economy at large. To address the 'who...
Saved in:
| Published in | Drug discovery today Vol. 20; no. 12; pp. 1429 - 1432 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
01.12.2015
|
| Online Access | Get full text |
Cover
Loading…
| Abstract | Genomic cancer medicine promises revolutionary change in oncology. The impacts of 'personalized medicine', based upon a molecular classification of cancer and linked to targeted therapies, will extend from individual patient outcomes to the health economy at large. To address the 'whole-of-system' impact of genomic cancer medicine, we have established a prospective cohort of patients with newly diagnosed cancer in the state of Victoria, Australia, about whom we have collected a broad range of clinical, demographic, molecular, and patient-reported data, as well as data on health resource utilization. Our goal is to create a model for investigating public investment in genomic medicine that maximizes the cost:benefit ratio for the Australian community at large. |
|---|---|
| AbstractList | Genomic cancer medicine promises revolutionary change in oncology. The impacts of 'personalized medicine', based upon a molecular classification of cancer and linked to targeted therapies, will extend from individual patient outcomes to the health economy at large. To address the 'whole-of-system' impact of genomic cancer medicine, we have established a prospective cohort of patients with newly diagnosed cancer in the state of Victoria, Australia, about whom we have collected a broad range of clinical, demographic, molecular, and patient-reported data, as well as data on health resource utilization. Our goal is to create a model for investigating public investment in genomic medicine that maximizes the cost:benefit ratio for the Australian community at large. |
| Author | Thomas, David M Lipton, Lara Richardson, Gary McNeil, John Parisot, John P Lucas, Mark Ashley, David Lorgelly, Paula K Fox, Stephen |
| Author_xml | – sequence: 1 givenname: David surname: Thomas middlename: M fullname: Thomas, David M – sequence: 2 givenname: Stephen surname: Fox fullname: Fox, Stephen – sequence: 3 givenname: Paula surname: Lorgelly middlename: K fullname: Lorgelly, Paula K – sequence: 4 givenname: David surname: Ashley fullname: Ashley, David – sequence: 5 givenname: Gary surname: Richardson fullname: Richardson, Gary – sequence: 6 givenname: Lara surname: Lipton fullname: Lipton, Lara – sequence: 7 givenname: John surname: Parisot middlename: P fullname: Parisot, John P – sequence: 8 givenname: Mark surname: Lucas fullname: Lucas, Mark – sequence: 9 givenname: John surname: McNeil fullname: McNeil, John |
| BookMark | eNqVjDsOwjAQRF2AxPcGFFvSJHjzg6RFIA4ANbKcDRg5NmQTIW5PEFyAaqQ3b2YiBs47EmKBMkSJ2eoWlk1XGg4jiWmPQinzgRhjnOZBliTZSEyYb1JilKfZWJy2ymlq4GMXoMB6dzFtf-CUhefVWwp8FfCLW6qB--IFvoILOV8bDfo7rqk02jgqYE-q7RqaiWGlLNP8l1Ox3O-O20Nwb_yjI27PtWFN1ipHvuMzbjBdY4RxHP-hvgFf8UwA |
| ContentType | Journal Article |
| DBID | 8FD FR3 P64 RC3 |
| DOI | 10.1016/j.drudis.2015.10.009 |
| DatabaseName | Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts |
| DatabaseTitle | Genetics Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts |
| DatabaseTitleList | Genetics Abstracts |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Engineering Pharmacy, Therapeutics, & Pharmacology |
| EndPage | 1432 |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 5VS 7-5 71M 8FD 8P~ AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAXKI AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABOCM ABUDA ABZDS ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AKRWK ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FR3 FYGXN G-Q GBLVA HVGLF IH2 IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P P64 PC. Q38 RC3 RIG ROL RPZ SCC SDF SDG SES SPCBC SSP SSU SSZ T5K ~G- |
| ID | FETCH-proquest_miscellaneous_18157121333 |
| ISSN | 1359-6446 |
| IngestDate | Fri Oct 25 02:55:53 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-proquest_miscellaneous_18157121333 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 23 ObjectType-Feature-2 |
| PQID | 1815712133 |
| PQPubID | 23462 |
| ParticipantIDs | proquest_miscellaneous_1815712133 |
| PublicationCentury | 2000 |
| PublicationDate | 20151201 |
| PublicationDateYYYYMMDD | 2015-12-01 |
| PublicationDate_xml | – month: 12 year: 2015 text: 20151201 day: 01 |
| PublicationDecade | 2010 |
| PublicationTitle | Drug discovery today |
| PublicationYear | 2015 |
| SSID | ssj0012956 |
| Score | 4.393794 |
| Snippet | Genomic cancer medicine promises revolutionary change in oncology. The impacts of 'personalized medicine', based upon a molecular classification of cancer and... |
| SourceID | proquest |
| SourceType | Aggregation Database |
| StartPage | 1429 |
| Title | Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine: Feature |
| URI | https://search.proquest.com/docview/1815712133 |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT8JAEN0oXvRgFDV-Z00MMZESWrrl42YQQgwih5Jwa7alqzGmTYDG4MHf7kx3SzdiInppYFO20HnMTmfevCXkujqxRL0pTAOeDYRhB6ZtcCF8oxpyzu0G_EfS9ujHgdMb2Q9jNtY6rrG7ZO5Xgo8f-0r-Y1UYA7til-wfLLucFAbgNdgXjmBhOK5l4zaabHoLqyuTTctvMW4_lEzSra7ecetbIxaGVGuWSrIYHKIuK1LiA_nxrLyOU2BEqDRGspD1fpo8Yx0nQLInxqoa70bSi5bc-Dy1qhY1xSHLRvuYf1d7WyMlkWt8gdmLyp7nLHuVjDCZRuyQ_rPGmgaEWI7uYK2qDiRLc5emrdIdoXorc50rbl1mGF4rkyncQRRZN1kl5eQ182UsK90PnrzuqN_33M7Y3SRbFjgg9HyVzyX1B0KcdFff5ZfNWipT3t_qNVaW6TT2cPfIrnpooHcSAftkI4yKZEeTkiyS0lBqkC_K1M1b6mZlWqLDXJ18cUBGEjQUr9yinOqQod8gQ1PI0FhQBRkqIUMzyLSoAswhuel23HbPyH6CB_4Di0I8CuNk5kGEx-qo61erHZFCFEfhMaE1CPIbAou2QWA3GIpU-dxhfOIL5vj1-gm5-nW60zXOOSPbOYrOSWE-TcILCPLm_mVqsS_Y81he |
| link.rule.ids | 315,783,787,27936,27937 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cancer+2015%3A+a+longitudinal+whole-of-system+study+of+genomic+cancer+medicine%3A+Feature&rft.jtitle=Drug+discovery+today&rft.au=Thomas%2C+David+M&rft.au=Fox%2C+Stephen&rft.au=Lorgelly%2C+Paula+K&rft.au=Ashley%2C+David&rft.date=2015-12-01&rft.issn=1359-6446&rft.volume=20&rft.issue=12&rft.spage=1429&rft.epage=1432&rft_id=info:doi/10.1016%2Fj.drudis.2015.10.009&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-6446&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-6446&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-6446&client=summon |